MAUDE Adverse Event Report: CERNER CORP. POWERCHART; MEDICAL COMPUTERS AND SOFTWARE

Device Problem Inadequate User Interface (2958)

Patient Problem No Clinical Signs, Symptoms or Conditions (4582)

Event Type  malfunction  

Event Description

Potential for error due to the cumbersome process required to verify medications in the cerner ehr/emr platform.Received an order for lovenox 30 mg subcut once daily for an inpatient.In cerner the order verification queue is in an app called powerchart.However, in order to verify the medication you must select "view" or "process" in powerchart which prompts the opening of the medsmanager app for verification.From medsmanager you can not see any documentation from physicians, home meds, or hospital plans for the patient.You can only see their most recent labs, reason for visit, and current meds.If you want to review patients chart for any surgical plans, issues with bleeding, diagnoses, md and specialist notes, imagining etc you must go back to power chart.This is a lot of flipping back and forth and potential for error.I found that powerchart for that patient doesn't open when in meds manager and even with it being just one order i found that i had a different patient open in each app.At this time no plans other than all pharmacist now have two computer monitors to try to manage to apps within the server platform.Hopeful to switch emrs in the future.As a pharmacist coming from epic use the last several years i am extremely concerned with cerner's emr and its potential for errors that i have seen since using it this last year.I am uncomfortable with this platform despite adequate training and 12 months of use.It is a ticking time bomb.Prescription processing software communication, poor/lacking (nonspecific).Circumstances or events have capacity to cause error.(b)(4).

• Brand Name: POWERCHART
• Type of Device: MEDICAL COMPUTERS AND SOFTWARE
• Manufacturer (Section D): CERNER CORP.
• MDR Report Key: 14776435
• MDR Text Key: 294657653
• Report Number: MW5110423
• Device Sequence Number: 1
• Product Code: LNX
• Combination Product (y/n): N
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Voluntary
• Reporter Occupation: Pharmacist
• Type of Report: Initial
• Report Date: 06/21/2022

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Date FDA Received: 06/21/2022
• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Patient Sequence Number: 1
• Treatment: LOVENOX 30 MG, ROUTE: SUBCUTANEOUS